Skye Bioscience Shows 18.1% vs 49.8% Weight Regain in Phase 2
Skye Bioscience (Nasdaq: SKYE) will present a late-breaking oral abstract…
AIM ImmunoTech Announces SITC 2025 Late-Breaking Abstract
AIM ImmunoTech (NYSE American: AIM) announced that data from a…
ProKidney Announces Late‑Breaking Phase 2 REGEN‑007 Poster
ProKidney (Nasdaq: PROK) will present two posters at the American…